Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elmar Kraus is active.

Publication


Featured researches published by Elmar Kraus.


Archive | 2010

Agent for treating disease

Matthias Germer; Frank Osterroth; Silke Aigner; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken


Archive | 2008

Agents targeting CD138 and uses thereof

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Matthias Germer; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Gregor Schulz


Archive | 2008

Immunoconjugates targeting cd138 and uses thereof

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer


Archive | 2008

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

Gregor Schulz; Christoph Bruecher; Frank Osterroth; Steffen Zeng; Christoph Uherek; Silke Aigner; Benjamin Daelken; Markus Ruehle; Elmar Kraus


Archive | 2009

DOSING REGIMEN FOR TREATING PSORIASIS AND RHEUMATOID ARTHRITIS

Frank Osterroth; Silke Aigner; Matthias Germer; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken; Gregor Schulz


Archive | 2009

Anti-CD4 antibody dosage regimen for treating autoimmune disease

Silke Aigner; Matthias Germer; Frank Osterroth; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken; Gregor Schulz


Archive | 2008

Wirkstoffe für CD138-Targeting und Verwendungen davon

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Matthias Germer; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Gregor Schulz


Archive | 2008

Immunoconjugués ciblant cd138 et utilisations de ceux-ci

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer


Archive | 2008

Verfahren zur verminderung der zytotoxischen nebenwirkungen und zur erhöhung der wirksamkeit von immunkonjugaten

Silke Aigner; Christoph Bruecher; Benjamin Daelken; Elmar Kraus; Frank Osterroth; Markus Ruehle; Gregor Schulz; Christoph Uherek; Steffen Zeng


Archive | 2008

Auf cd138 zielende immunkonjugate und anwendungen davon

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer

Collaboration


Dive into the Elmar Kraus's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christoph Uherek

Goethe University Frankfurt

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christoph Uherek

Goethe University Frankfurt

View shared research outputs
Researchain Logo
Decentralizing Knowledge